Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 25, 2026

Trump Signals Progress in Iran Talks: 5 Beaten-Down ETFs to Rally

View original at finance.yahoo.com
Trump Signals Progress in Iran Talks: 5 Beaten-Down ETFs to Rally President Donald Trump indicated that Iran had offered a “present” as a gesture of goodwill amid ongoing negotiations to end the 25-day conflict that has rattled global markets, per Bloomberg, as quoted on Yahoo Finance…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • S&P 500 year-end target reduced to 7,200 from 7,500 due to potential oil supply shock linked to Strait of Hormuz disruptions

    60% confidence
  • Geopolitical risks are limiting upside for equities

    60% confidence
  • Year-end target for S&P 500 Index reduced to 7,200 from 7,500 due to potential oil supply shock linked to Strait of Hormuz disruptions

    60% confidence
  • Iran had offered a present as a gesture of goodwill amid ongoing negotiations

    60% confidence
  • A key U.S. condition for any agreement is preventing Iran from acquiring nuclear weapons

    60% confidence
  • S&P 500 year-end target reduced to 7,200 from 7,500 citing potential oil supply shock linked to disruptions in the Strait of Hormuz

    60% confidence
  • A key U.S. condition for any agreement is preventing Iran from acquiring nuclear weapons

    60% confidence
  • Iran had offered a 'present' as a gesture of goodwill

    60% confidence
  • A key U.S. condition for any agreement is preventing Iran from acquiring nuclear weapons

    60% confidence
  • The Iranian offer was worth a tremendous amount of money and tied to energy flows through the Strait of Hormuz

    60% confidence
  • The offer from Iran is worth a tremendous amount of money

    60% confidence
  • Despite the downgrade, JPMorgan's revised target still suggests good upside from current levels by year-end

    60% confidence
  • The offer was 'worth a tremendous amount of money'

    60% confidence
  • The offer was tied to energy flows through the Strait of Hormuz

    60% confidence
  • Iran had offered a 'present' as a gesture of goodwill amid ongoing negotiations

    60% confidence
  • Geopolitical risks are limiting upside for equities

    60% confidence
  • Geopolitical risks are limiting upside for equities

    60% confidence
  • Iran's offer was tied to energy flows through the Strait of Hormuz

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Trump Signals Progress in Iran Talks: 5 Beaten-Down ETFs to Rally — Source | Via News | Finance Via News